BMP Pharma Trading AG (STU:BMP) Short-Term Debt: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:BMP BMP Pharma Trading AG STU:BMP
36 GF Score
Price €6.20
! 2 Warning Signs
View Full Analysis

What is BMP Pharma Trading AG Short-Term Debt?

BMP Pharma Trading AG STU:BMP 36 Short-Term Debt is €0.00 Mil as of Dec. 2025. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

BMP Pharma Trading AG's Short-Term Debt for the quarter that ended in Dec. 2025 was €0.00 Mil.

BMP Pharma Trading AG's quarterly Short-Term Debt declined from Dec. 2024 (€0.13 Mil) to Jun. 2025 (€0.00 Mil) but then stayed the same from Jun. 2025 (€0.00 Mil) to Dec. 2025 (€0.00 Mil).

BMP Pharma Trading AG's annual Short-Term Debt declined from Dec. 2023 (€0.26 Mil) to Dec. 2024 (€0.13 Mil) and declined from Dec. 2024 (€0.13 Mil) to Dec. 2025 (€0.00 Mil).

BMP Pharma Trading AG Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

BMP Pharma Trading AG Short-Term Debt Related Terms

BMP Pharma Trading AG Short-Term Debt Historical Data

* Premium members only.

The historical data trend for BMP Pharma Trading AG's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BMP Pharma Trading AG Short-Term Debt Chart

BMP Pharma Trading AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.38 0.26 0.13 0.00

BMP Pharma Trading AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.00 0.13 0.00 0.00
STU:BMP
36GF Score
BMP Pharma Trading AG STU:BMP
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €0.00 Mil mean?
BMP Pharma Trading AG (STU:BMP) has a Short-Term Debt of €0.00 Mil as of Dec. 2025.
Is BMP Pharma Trading AG's Short-Term Debt too high?
BMP Pharma Trading AG's current Short-Term Debt is €0.00 Mil. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Short-Term Debt compare to MCK and COR?
BMP Pharma Trading AG's Short-Term Debt of €0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. BMP Pharma Trading AG's current Short-Term Debt is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Short-Term Debt of €0.00 Mil. The current Short-Term Debt is €0.00 Mil. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Short-Term Debt is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BMP Pharma Trading AG Business Description

Address Bornbarch 16, Norderstedt, SH, DEU, 22848
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score

Get the complete analysis for STU:BMP

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.20
Price